Dublin, Feb. 28, 2018 (GLOBE NEWSWIRE) -- The "3D Cell Culture Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The 3D cell culture global market is expected to grow at double digit CAGR to reach $1,485.1 million by 2024.
Substantial R&D investments, use of 3D cell culture models in drug discovery and research as alternative to animal testing, emergence of microfluidic technology and bioprinting and increasing focus on regenerative medicine are some of the driving factors for this industry. However, lack of experienced and skilled professionals, budget restrictions for small and medium sized laboratories, lack of consistency in 3D cell culture products, stringent process controls for handling capabilities and ethical concerns over the use of animal sources are hindering the market to grow.
3D cell culture global market is classified based on technology, products, application, end-users, and geography. Based on technology the 3D cell culture market can be divided into two segments i.e., Scaffold based approaches and Scaffold free approaches. The scaffold based approaches are further classified into scaffolds, hydrogels and others. The scaffold free approaches are classified as the hang drop method, forced floating, agitation based methods, and microfludics.
Based on products the segment is further classified as cells and tissues, media, sera and reagents, microplates and others, assay kits, scaffolds, and others (bioreactors and incubators). The application segment can be classified as basic research, toxicity and drug screening, tissue engineering, stem cell research, drug discovery, gene therapy and cancer research. The end-users segment can be classified as academic institutes, biotechnology and pharmaceutical industries and others.
Based on geography 3D cell culture global market is classified as North America, Europe, APAC and Rest of the world. North America accounts for the highest market share of 46.2% followed by Europe. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for 3D cell culture products.
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 Key Takeaways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Breakdown And Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points From Secondary Sources
2.5.6 Key Data Points From Primary Sources
2.5.7 Assumptions
3. Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Substantial R&D Investments For 3D Cell Culture
3.3.1.2 Use Of 3D Cell Culture Models In Drug Discovery And Research As An Alternative To Animal Testing
3.3.1.3 Emergence Of Microfluidic Technology And Bioprinting
3.3.1.4 Increasing Focus On Regenerative Medicine
3.3.2 Restraints And Threats
3.3.2.1 Lack Of Experienced And Skilled Professionals
3.3.2.2 Budget Restriction For Small And Medium Sized Laboratories And Lack Of Consistency In 3D Cell Culture Products
3.3.2.3 Stringent Process Controls For Advanced Handling Capabilities
3.3.2.4 Ethical Concern Over Use Of Animal Sources
3.4 Regulatory Affairs
3.4.1 United States
3.4.2 Europe
3.4.3 India
3.4.4 Japan
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Organ-On-Chip
3.5.3 3D Bioprinting
3.5.4 Single Use Reactors
3.6 Porter's Five Force Analysis
3.7 Supply Chain Analysis
3.8 Market Share Analysis By Major Players
4. 3D Cell Culture Global Market, By Technology
4.1 Introduction
4.2 Scaffold Based Platforms
4.2.1 Scaffolds
4.2.2 Hydrogels
4.2.3 Others
4.3 Scaffold Free Platforms
4.3.1 Hang Drop Method
4.3.2 Forced Floating
4.3.3 Agitation Based Methods
4.3.4 Microfluidics
5. 3D Cell Culture Global Market, By Products
5.1 Introduction
5.2 Cells And Tissues
5.3 Media, Sera And Reagents
5.4 Microplates And Others
5.5 Assay Kits
5.6 Scaffolds
5.6.1 Natural Scaffolds
5.6.2 Synthetic Scaffolds
5.6.3 Hybrid Composite
5.6.4 Hydrogels
5.7 Others
6. 3D Cell Culture Global Market, By Application
6.1 Introduction
6.2 Basic Research
6.3 Toxicity And Drug Safety Screening
6.4 Tissue Engineering
6.5 Stem Cell Research
6.6 Drug Discovery
6.7 Cancer Research
6.8 Gene Therapy
7. 3D Cell Culture Global Market, By End-Users
7.1 Introduction
7.2 Academic Institutes
7.3 Biotechnology And Pharmaceutical Industries
7.4 Others
8. Regional Analysis
9. Competitive Landscape
9.1 Introduction
9.2 Collaborations & Partnerships
9.3 New Product Launches
9.4 Agreements, Expantions & Mergers
9.5 Company Matrix
10. Major Companies
- 3D Matrix Co (Japan)
- AMSBio LLC (U.S.)
- Ascendance (U.S.)
- Becton Dickenson & Company (U.S.)
- BioCellChallenge (France)
- Biolamina AB (Sweden)
- CellecBiotek AG (Switzerland)
- CelVivo IVS (Denmark)
- Corning (U.S.)
- Cytoo (France)
- Fujifilm (Japan)
- Hurel Corp (U.S.)
- Insphero (Switzerland)
- JSR Corporation (Organogenix Inc.)(Japan)
- Kuraray Co. Ltd. (Japan)
- Lonza (Switzerland)
- Merck KGaA (Germany)
- Nano 3D Biosciences (U.S.)
- Nanopahrma AS (Czech Republic)
- Organovo Holdings Inc. (U.S.).
- Prodizen (Korea)
- Thermofisher Scientific (U.S.)
For more information about this report visit https://www.researchandmarkets.com/research/6npdgw/globa_3d_cell?w=12